Stephen O. Richard

Stephen O. Richard joined the Board of Directors of Anika Therapeutics in September 2020. Mr. Richard currently serves as Chief Risk Officer and Chief Audit Executive at Becton, Dickinson and Company (BD). He joined BD in February 2016 and is responsible for the oversight of Enterprise Risk Management, Internal Audit, Information Security (enterprise), Product Security (connected devices), Corporate Security and Aviation, helping to align practices for each of these areas with best-in-class organizations and deliver value through continued focus on risk, governance and effective partnership with the business. Prior to joining BD, Mr. Richard held positions of increasing responsibility in Finance, Operations and Business Development with the National Basketball Association (NBA) over the course of an 18-year career. His NBA tenure also included three years based in Beijing, China, where he served as Chief Financial Officer and interim Chief Executive Officer. Prior to the NBA, he held leadership positions with Citibank, AT&T and Deloitte. Mr. Richard holds an MBA in Finance from Columbia Business School and a BS in Accounting from Northeastern University. He is a licensed Certified Public Accountant in the State of New Jersey and current Chairman of the Committee on Governance, Risk and Compliance of Financial Executives International. He also serves on the Advisory Board to the Center for Excellence in ERM at St. John's University. Mr. Richard is also a member of the Executive Leadership Council and has served two past three-year terms on the board of the New Jersey Society of CPAs. Finally, he is a life member of Kappa Alpha Psi Fraternity, Inc. Mr. Richard serves as the Chair of the Audit Committee.